Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Neuroendocrine Tumors 2Lymphoma 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Osteosarcoma 1Neurodegenerative Diseases 1Myocarditis 1Hematologic Neoplasms 1Esophageal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Surveys and Questionnaires 7Interviews as Topic 7Blood Specimen Collection 5Specimen Handling 4Exercise Test 4fludarabine 3Voriconazole 3Mental Status and Dementia Tests 3Bortezomib 3Standard of Care 2Observation 2Itraconazole 2Flow Cytometry 2Electronic Health Records 2Data Collection 2Antiviral Agents 2posaconazole 1liposomal amphotericin B 1isavuconazole 1glucarpidase 1fludarabine phosphate 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Whole-Body Irradiation 1Watchful Waiting 1Vincristine 1Valganciclovir 1Transplantation 1Tomography, X-Ray Computed 1Tomography, Optical Coherence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hematologic Neoplasms × Positron-Emission Tomography × Clear all
NCT06566209 2026-05-08

FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis

Mayo Clinic

Terminated
2 enrolled
Other hematologic neoplasm

Myocarditis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡